Implementation of the MASK-Air® App for Rhinitis and Asthma in Older Adults: MASK@Puglia Pilot Study

MASK-air® is an app whose aim is to reduce the global burden of allergic rhinitis and asthma. A transfer of innovative practices was performed to disseminate and implement MASK-air® in European regions. The aim of the study was to examine the implementation of the MASK-air® app in older adults of th...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:International archives of allergy and immunology Ročník 183; číslo 1; s. 45
Hlavní autoři: Ventura, Maria Teresa, Giuliano, Antonio Francesco Maria, Buquicchio, Rosalba, Bedbrook, Anna, Czarlewski, Wienczyslawa, Laune, Daniel, Patella, Vincenzo, Canonica, Giorgio Walter, Bousquet, Jean
Médium: Journal Article
Jazyk:angličtina
Vydáno: Switzerland 2022
Témata:
Age Factors
Aged
Aged, 80 and over
Asthma - epidemiology
Asthma - prevention & control
Europe - epidemiology
Female
Follow-Up Studies
Humans
Male
Mobile Applications
Patient Acceptance of Health Care
Pilot Projects
Rhinitis, Allergic - epidemiology
Rhinitis, Allergic - prevention & control
Self Care - methods
Self Care - statistics & numerical data
Europe
mHealth
MASK-Air
Rhinitis
Elderly
Asthma
ISSN:1423-0097, 1423-0097
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:MASK-air® is an app whose aim is to reduce the global burden of allergic rhinitis and asthma. A transfer of innovative practices was performed to disseminate and implement MASK-air® in European regions. The aim of the study was to examine the implementation of the MASK-air® app in older adults of the Puglia TWINNING in order to investigate (i) the rate of acceptance in this population, (ii) the reasons for refusal and (iii) the evaluation of the app after its use. All consecutive geriatric patients aged between 65 and 90 years were included by the outpatient clinic of the Bari Geriatric Immunoallergology Unit. After a 1-h training session, older adults used the app for 6 months. A 6-item questionnaire was developed by our unit to evaluate the impact of the app on the management of the disease and its treatment. Among the 174 recruited patients, 102 accepted to use the app (mean age, SD: 72.4 ± 4.6 years), 6 were lost to follow-up, and 63 had a low education level. The reasons given not to use the app included lack of interest (11%), lack of access to a smartphone or tablet (53%), low computer literacy (28%), and distrust (8%). At follow-up, the overall satisfaction was high (89%), the patient considered MASK-air® "advantageous" (95%), compliance to treatment was improved (81%), and the rate of loss to follow-up had decreased to 6%. Older adults with a low level of education can use the MASK-air® app after a short training session.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1423-0097
1423-0097
DOI:10.1159/000518032